We’re making history, one milestone at a time
Follow our progress as we work toward our vision of improving outcomes for people with cancer.
Tizona News
October 14, 2021
Tizona Initiates Phase 1b Expansion Study of TTX-080 in Advanced Refractory or Resistant Malignancies